USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Asia-Pacific Next-generation Diagnostics Outlook, 2023
The Renewed Focus on Infectious Diseases Outside COVID-9, Oncology, Cardiovascular, Diabetes, and Prenatal Care will Drive Market Growth
20-Apr-2023
Asia Pacific
Market Outlook
PE5C-01-00-00-00
HC03653-AP-MO_27562
$4,950.00
Special Price $3,712.50 save 25 %
The Asia-Pacific next-generation diagnostics market's revenue is projected to decline by 5.0% in 2023, attributed to the reduced demand for COVID-19-related testing. Rapid expansion in non-COVID molecular diagnostics and point-of-care testing (POCT) will not be sufficient to drive the overall recovery of the region. As companies continue to focus on breakthrough innovation, diagnostic services must be revamped to meet reduced price points for low-resource settings.
The pandemic led to a greater focus on preventive diagnosis. Innovation in product development, a focus on care delivery and business models, and the need for more convenient sampling are leading to a paradigm shift to minimally invasive tests. Global IVD powerhouses remain at the vanguard of this transformation. Prominent market participants are Roche Diagnostics, Abbott Laboratories, Danaher Corporation, Siemens Healthineers, and Sysmex Corporation, while regional IVD powerhouses are making a strategic shift to leverage the platform-as-a-service business model, implying momentum in secured and connected open development platforms to support rapid and standardized assay development. Trends point toward a focus on infectious diseases outside COVID-19, molecular oncology, cardiovascular disease, and diabetes, with an emerging focus on noninvasive prenatal testing (NIPT).
Author: Amartya Bose
Study Highlights
Top Next-generation Diagnostics Industry Predictions—2023
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Next-generation Diagnostics Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Segmentation
Growth Environment
Top 5 Global Economic Highlights—2023
Global GDP Growth Snapshot
Advanced Economies’ Predictions—2023
Emerging Economies’ Predictions—2023
Regional Risks and Policy Direction—2023
Supply Chain Disruptions—Impact Analysis
Innovation—Impact Analysis
Commercial Success—Impact Analysis
Revenue Forecast by Segment
Revenue Forecast by Segment (continued)
Competitive Environment
Revenue Share
Revenue Share Analysis
Revenue Forecast by Country
Revenue Forecast Analysis by Country
Prediction 1—Infectious Disease Testing will Largely Transition to POC Rapid Tests
Prediction 2—Comprehensive POCT Solutions in Diabetes Care will Proliferate to Empower Fast Clinical Decision Making
Prediction 3—A Spike in Population-sequencing Efforts will Drive NGS Market Expansion
Prediction 4—Demand for Cardiac Biomarker Testing in Hospitals will Drive Clinical Chemistry and Immunoassay Market Growth in China
Market Snapshot—2023
Market Snapshot—Clinical Chemistry and Immunoassays
Market Snapshot—Molecular Diagnostics
Market Snapshot—POCT
Growth Opportunity 1: POC Rapid Testing
Growth Opportunity 1: POC Rapid Testing (continued)
Growth Opportunity 2: NIPT
Growth Opportunity 2: NIPT (continued)
Growth Opportunity 3: Comprehensive Cancer Genomic Profiling Services
Growth Opportunity 3: Comprehensive Cancer Genomic Profiling Services (continued)
Conclusion
Your Next Steps
Why Frost, Why Now?
List of Exhibits
Legal Disclaimer
List of Figures
- Next-generation Diagnostics: Implications for Key Stakeholders, Asia-Pacific, 2022 and 2023
- Next-generation Diagnostics: Revenue Forecast by Segment, Asia-Pacific, 2022 and 2023
- Next-generation Diagnostics: Revenue Share of Top Participants, Asia-Pacific, 2022
- Next-generation Diagnostics: Revenue Forecast by Region, Asia-Pacific, 2022–2027
- Next-generation Diagnostics: Market Share by Country, Asia-Pacific, 2023
- Next-generation Diagnostics: Market Share by Segment, Asia-Pacific, 2023
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-car...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Outlook |
|---|---|
| Author | Amartya Bose |
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | Next-Generation Diagnostics Market |
| Keyword 2 | Ivd Market |
| Keyword 3 | In-Vitro Diagnostics Market |
| List of Charts and Figures | Next-generation Diagnostics: Implications for Key Stakeholders, Asia-Pacific, 2022 and 2023~ Next-generation Diagnostics: Revenue Forecast by Segment, Asia-Pacific, 2022 and 2023~ Next-generation Diagnostics: Revenue Share of Top Participants, Asia-Pacific, 2022~ Next-generation Diagnostics: Revenue Forecast by Region, Asia-Pacific, 2022–2027~ Next-generation Diagnostics: Market Share by Country, Asia-Pacific, 2023~ Next-generation Diagnostics: Market Share by Segment, Asia-Pacific, 2023~ |
| Podcast | No |
| WIP Number | PE5C-01-00-00-00 |